Breaking News

BioReliance Gets Screening Contract from EPA

Will screen 1,000 chemicals to forecast toxicity

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

BioReliance has been awarded a contract under the U.S. Environmental Protection Agency’s (EPA) Computational Toxicology Research Program called ToxCast. This contract for the testing of high throughput complex cell co-culture systems encompasses genetic toxicology screening of environmental chemicals for potential toxicity. In the initial scope of this contract, BioReliance will test 1,000 chemicals under Phase II of the Toxicity Forecaster (ToxCast) program. These chemicals come from a broad r...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters